Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
-0.763 %
$ 75.1 M
Market Cap
-0.87
P/E
AVTE - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss AVTE - Aerovate Therapeutics, Inc.
237 K
LAST VALUE
145.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR